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Abstract
Background: Metabolic imaging has revealed excessive cerebellar activity in essential tremor patients. Golgi cells control cerebellar activity by releasing gamma-
aminobutyric acid (GABA) onto synaptic and extrasynaptic receptors on cerebellar granule cells. We postulated that the extrasynaptic GABAA receptor-specific
agonist THIP (gaboxadol; 4,5,6,7-tetrahydroisoxazolo[5,4-c]pyridin-3-ol) would suppress tremor in the harmaline model of essential tremor and, since cerebellar
extrasynaptic receptors contain a6 and d subunits, would fail to do so in mice lacking either subunit.
Methods: Digitally measured motion power, expressed as 10–16 Hz power (the tremor bandwidth) divided by background 8–32 Hz motion power, was accessed
during pre-harmaline baseline, pre-THIP harmaline exposure, and after THIP administration (0, 2, or 3 mg/kg). These low doses were chosen as they did not
impair performance on the straight wire test, a sensitive test for psychomotor impairment. Littermate d wild-type and knockout (Gabrd+/+, Gabrd–/–) and littermate
a6 wild-type and knockout (Gabra6+/+, Gabra6–/–) mice were tested.
Results: Gabrd+/+ mice displayed tremor reduction at 3 mg/kg THIP but not 2 mg/kg, and Gabra6+/+ mice showed tremor reduction at 2 and 3 mg/kg.
Their respective subunit knockout littermates displayed no tremor reduction compared with vehicle controls at either dose.
Discussion: The loss of anti-tremor efficacy with deletion of either d or a6 GABAA receptor subunits indicates that extrasynaptic receptors containing both
subunits, most likely located on cerebellar granule cells where they are highly expressed, mediate tremor suppression by THIP. A medication designed to activate
only these receptors may display a favorable profile for treating essential tremor.
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Introduction
Tremor expression in essential tremor (ET) involves an oscillatory
network that includes the cerebellum, thalamus, motor cortex, and
brainstem, as shown by magnetoencephalography.1 Thalamic deep
brain stimulation (DBS) therapy acts by affecting cerebellar outflow to
the cerebrum. ET patients exhibit numerous anomalies of cerebellar
function, including imbalance, irregular finger tapping, and eye move-
ment anomalies,2 some of which improve with successful tremor treatment.
Transcranial magnetic stimulation of the cerebellum improves tremor.3
These and other observations indicate the cerebellum’s critical role in ET.
Purkinje cells provide the sole output from cerebellar cortex; these
cells receive a massive excitatory input via parallel fibers from granule
cells, which in turn receive massive excitatory inputs from ascending
mossy fibers. Evidence that this entire cerebellar cortical system is
excessively active in ET is provided by positron imaging scans that
Freely available online
Tremor and Other Hyperkinetic Movements
http://www.tremorjournal.org Columbia University Libraries1
June 26, 2018
demonstrate increased blood flow in the cerebellum.4 The notion of
cerebellar cortical over-activity is further reinforced by clinical observa-
tions that tremor in ET is abolished by strokes involving the pons,5
where excitatory afferent mossy fibers originate.
A critical control point for cerebellar cortical activity is the Golgi
cell, which receives excitatory inputs from granule cells, mossy fibers,
and climbing fiber collaterals, and releases gamma-aminobutyric acid
(GABA) onto granule cells. GABAA receptors may be divided into two
main classes. Synaptic receptors are pentameric structures containing
two a, two b, and one c subunit, and mediate fast signaling. Extra-
synaptic receptors are also pentameric but utilize a d rather than a
c subunit, usually contain a4 or a6 subunits, exhibit sensitivity to low
GABA levels, and exert tonic rather than phasic inhibition. These
properties permit granule cell extrasynaptic GABAA receptors to
exert powerful control over cerebellar cortical activity. In contrast
to d GABAA receptors elsewhere in the brain that usually contain a4,
those of cerebellar granule cells utilize a6 subunits.6
Based on these considerations, we postulated that if a drug were to
suppress tremor and require the presence of d and a6 GABAA receptor
subunits for this action, such a finding would indicate the potential for
extrasynaptic a6bd GABAA receptor activation to treat ET, most likely
on cerebellar granule cells.
Considerable research has shown that THIP (gaboxadol; 4,5,6,7-
tetrahydroisoxazolo[5,4-c]pyridin-3-ol) is a highly selective agonist for
extrasynaptic GABAA receptors at low doses; it activates recombinant
a4bd and a6bd receptors at concentrations 1,000 times lower than
those required to activate a4bc2 and a6bc2 receptors.7 Slices taken
from the thalamus or cerebellum of wild-type (WT) mice, but not those
from d-knockout (KO) mice, respond to low THIP concentrations with
tonic inhibitory currents.7,8 Doses of THIP that cause incoordination
on the rotarod test in WT mice fail to do so in d-KO mice.8 Given this
specificity of low-dose THIP for extrasynaptic receptors, we utilized this drug
in the harmaline model of ET to evaluate the hypothesis that activation of
GABAA receptors containing d and a6 subunits may suppress tremor.
Methods
Animals
Gabrd–/– mice (also referred to as d–/–), generated with a disruption
of exon 4,9 and backcrossed with C57BL/6J mice for over 11 genera-
tions, were kindly donated by Dr. Martin Wallner at the University of
California at Los Angeles. Gabra6–/– mice (also referred to as a6–/–)
were obtained from Jackson Laboratories (#002710, Bar Harbor, ME).
These mice were created with a disruption of exon 8 of the gabra6 gene,
with background strains of C57BL/6J and 129/SvJ,10 and were
backcrossed with C57BL/6J mice in our laboratory for five genera-
tions. Heterozygotes of each genotype were generated, which were
then interbred to produce littermates (d+/+, d–/–; and a6+/+, a6–/–) for
harmaline experiments. Genotypes were determined commercially
from ear biopsies using real-time polymerase chain reaction with
specific probes designed for each gene (Transnetyx, Inc., Cordova, TN).
Male and female mice were used, and had ad libitum access to food and
water.
All procedures conformed to the National Institute of Health’s
Guide for the Care and Use of Laboratory Animals (NIH Publications
No. 80-23, revised 1978). All efforts were made to minimize animal
suffering and to reduce the number of animals used. Animal protocols
were approved by the Veterans Affairs Greater Los Angeles Insti-
tutional Animal Care and Use Committee.
Test procedures
In preliminary experiments, the ability of WT mice not receiving
harmaline to pass the straight wire test at various doses of THIP was
assessed, as previously described.11 This simple test is highly sensitive
to psychomotor impairment.12 In this test, a mouse is suspended by its
front paws from a rigid, 2-mm diameter wire and the time it takes the
mouse to bring a hind paw up to the wire is noted. To pass, a mouse
had to stay on the wire for 10 seconds and touch the wire with a hind
paw within that time, and pass on all tests conducted at 10-minute
intervals for 1 hour following drug administration. Only doses at which
six out of six mice passed all tests were utilized in harmaline experiments.
Harmaline tremor was assessed as previously described,11,13,14 but
with the modification that mice were placed on an elevated platform
on top of a cylinder that rested on the chamber floor fitted with a
motion detector. In brief, each mouse was placed on an 8.1-cm-
diameter mesh on top of a 24.1-cm-high cylinder. The cylinder rested
on a Convuls-1 replacement sensing platform model 1335-1A (Columbus
Instruments, Columbus, OH), which was fitted with a load sensor and
connected to a Grass model P511 AC amplifier (Grass Instruments, West
Warwick, RI) with 1 and 70 Hz filter settings. Digitally recorded motion
power was analyzed using Spike2 software (Cambridge Electronic Design,
UK) to perform Fourier transformation of the data into frequency spectra.
Data were sampled at 128 Hz. The motion power percentage (MPP) is the
tremor bandwidth divided by overall motion power (10–16 Hz power)/
(8–32 Hz power) 6 100.
Mice were acclimated to the platform; then, 15 minutes of pre-harmaline
baseline motion data were collected, and then harmaline (Sigma-Aldrich,
St. Louis, MO), 20 mg/kg in 4 mL saline/kg was injected subcutaneously.
Once the tremor had stabilized, motion power was assessed for 30 minutes
interrupted at 15 minutes by 5 minutes of rest in the home cage. THIP
(Tocris, Minneapolis, MN) was then administered in doses of 0, 2, or
3 mg/kg in saline, 10 mL/kg intraperitoneally, and motion power
accessed starting 10 minutes later for a total of 45 minutes, with 5-minute
interruptions at 15-minute intervals for rest periods in the home cage.
Tremor past this time was not analyzed, as it became highly variable due
to the harmaline wearing off. The technique of placing each mouse on an
elevated platform promotes alert behavior that is associated with action
tremor. Rest periods were designed to refresh the alert behavior once
back on the platform, enhancing tremor consistency. There were seven to
13 mice per group.
Statistics
Statistical comparisons of post-treatment MPP values between
groups that received 0, 2, or 3 mg/kg were performed. Statistical
significance between groups was determined using one-way analysis of
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variance, followed by post hoc Student’s t tests comparing THIP-treated
groups with the vehicle-treated group using the Bonferroni correction,
employing Excel (Microsoft). The two-tailed significance level was 0.05.
Results
Role of GABAA receptor d subunit in tremor suppression by THIP
Gabrd–/– and gabra6–/– mice, as previously described in the litera-
ture,9,10 display normal behavior without ataxia and are indistinguish-
able from littermate +/+ mice. The THIP dose 3 mg/kg was chosen as
the highest tested dose, as six out of six WT mice passed all straight
wire tests at this dose; this dose is below the dose of 4 mg/kg reported
to affect the electroencephalogram (EEG) in mice.15
During pre-harmaline baseline, the MPP was approximately 25–33%
on average, reflecting the percentage of motion power that happens to
fall within the 10–16 Hz tremor range during normal movement. With
harmaline administration to Gabrd+/+ mice, motion power became
dominated by tremor at 10–16 Hz, so that MPP approximated 80%
(Figure 1A). After THIP injection, motion power barely changed in
Gabrd+/+ mice administered 0 or 2 mg/kg (n 5 7, 8, respectively).
In contrast, the 3 mg/kg dose caused a significant reduction of motion
power, reflecting suppression of tremor (n 5 10, p 5 0.0005, two-tailed
Student’s t test), and lasted during the period of tremor measurement.
Gabrd–/– mice displayed pre-harmaline baseline and pre-THIP
harmaline MPP values similar to those of littermate d+/+ mice,
indicating no alteration in overall motion activity or tremor response
to harmaline. THIP, 2 mg/kg, did not affect tremor in d–/– mice
compared with mice given 0 mg/kg (n 5 11 and 13 respectively,
Figure 1B), nor did the 3 mg/kg dose reduce MPP significantly (n 5 7,
p 5 0.14, two-tailed Student’s t test). This result indicates that the
presence of the d subunit is required for tremor suppression by low-
dose THIP.
Role of GABAA receptor a6 subunit in tremor suppression by THIP
Gabra6+/+ mice displayed MPP values during baseline and pre-
THIP harmaline periods, and after 0 mg/kg THIP (n 510, Figure 2A),
that were similar to those of Gabrd+/+ mice. THIP significantly reduced
MPP after THIP at doses of 2 and 3 mg/kg compared with vehicle-
treated controls (n 5 11, p 5 0.006; n 5 10, p 5 0.024 respectively,
two-tailed Student’s t test).
Gabra6–/– mice, like Gabrd–/– mice, displayed MPP values during
pre-harmaline baseline and pre-THIP harmaline periods similar to
those of their WT littermates, indicating no alteration in general
motility or in their tremor response to harmaline (Figure 2B). How-
ever, compared with the 0 mg/kg THIP group (n 5 10), animals
receiving 2 or 3 mg/kg displayed no reduction in MPP values (n 5 9,
p 5 0.59; n 5 10, p 5 0.67, respectively; two-tailed Student’s t test),
indicating a failure of low-dose THIP to affect tremor in the absence of
the a6 subunit.
Discussion
Cerebellar GABAA receptors containing a6, both synaptic with c2
and extrasynaptic with d subunits, are highly expressed on granule cells.
Mice lacking d subunits display no reduction of cerebellar a6; however,
these mice display increased c2, reflecting a compensatory increase in
a6bc2 receptors.16,17 A deletion of a6, by contrast, results in a 50% loss
of cerebellar GABAA receptors, with severe depletion of both synaptic
and extrasynaptic receptors as shown by depletion of the d and c2
subunits.18,19 It may be noted that levels of a4, which is found in
extrasynaptic GABAA receptors in most brain regions, are very low in
cerebellum, and do not compensate for loss of a6.20 Despite the
loss of cerebellar granule cell GABA-mediated tonic currents,21 a6 KO
mice show no motor deficits, are agile, and perform well on the rotat-
ing rod.10,18,19,21 The compensation appears to be due to powerful
compensatory mechanisms in global KO animals, including upregula-
tion of a voltage-independent potassium conductance in cerebellar
granule cells. The latter compensatory change results in normalized
Figure 1. Effect of THIP on Harmaline-induced Tremor in Gabrd+/+
and –/– Littermates. (A) Motion power percentage, representing the portion
of 8–32 Hz motion power falling within the 10–16 Hz tremor bandwidth is
shown during pre-harmaline baseline (B), followed by pre-THIP exposure to
harmaline (H), and then following THIP injection (H + T) in Gabrd+/+ mice
that received 0, 2, or 3 mg/kg. These wild-type mice displayed robust 10–16 Hz
harmaline tremor that was reduced by THIP, 3 mg/kg. (B) In contrast,
littermate mice lacking the d subunit failed to display any tremor suppression
by THIP. Mean and standard error of the mean are shown; ***p , 0.001,
two-tailed Student t test.
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granule cell excitability.21 The relatively normal response by cerebellar
granule cells to multiple excitatory inputs thus may explain normal
motor agility and tremor response to harmaline in a6- and d-null mice;
however, the absence of these subunits permits the testing of drugs whose
behavioral action is hypothesized to depend on these subunits.
To our knowledge, there are no available drugs specific for activat-
ing a6bd GABAA receptors in vivo. Instead there are several agents
that activate extrasynaptic receptors more generally, including a1bd,
a4bd, and a6bd receptors. These include low-dose alcohol and neuro-
steroids, which act as positive allosteric modulators, and THIP, which
acts as an agonist on d receptors. In recombinant subunit-expressing
cells, THIP activates a4b3d and a6b3d receptors at sub-micromolar
levels, several orders of magnitude lower than those required to
activate a4/6b3c2 receptors.7 Slices of cerebellar granule cells, which
express a6bd receptors, respond with tonic currents to low levels of
THIP but fail to do so if taken from mice lacking d or a6 subunits.7,21
In brain regions outside the cerebellum, such as the thalamus, where
a4bd receptors are expressed, the tonic inhibitory response to low-level
THIP requires the presence of d and a4 subunits, as shown by using
the corresponding KO mice.8,22 The specificity of low-dose THIP for
extrasynaptic receptors GABAA receptors compared with synaptic
receptors has been confirmed at the behavioral level. WT mice
display impairment on the rotarod test after administration of THIP,
10 mg/kg, but not in d-subunit KO mice,8 whereas d subunit
upregulation in the hippocampus is associated with increased seizure
suppression by THIP.23 THIP at low doses of 4 and 6 mg/kg affects
the EEG in WT mice but not in d-subunit KO mice.15
In the present study, we employed the harmaline model of tremor
to test the hypotheses that GABAA receptors containing d and a6
subunits mediate tremor suppression by THIP. The harmaline model
is not a model of the disease ET, but of tremor that is the main
symptom of ET. Harmaline induces action tremor in rodents that
responds to alcohol and to standard ET therapies, and shares
numerous pharmacological and physiological features with ET.24
Harmaline acts by promoting inferior olive burst-firing, which then
recruits circuits that overlap with those implicated in ET. Like ET,
harmaline causes activation of components of the cerebellum, includ-
ing Purkinje cells, the inferior olive, and the deep cerebellar nuclei.
As in ET, harmaline tremor is suppressed by electrical stimulation of
the thalamus.25 Cerebellar granule cells are also activated during
harmaline tremor, as indicated by c-fos labeling.26,27 False positives
have been reported, in which drugs that suppress harmaline tremor do
not reduce tremor in ET patients;24 at least some of these disparities
were likely due to the use of doses that caused non-specific psycho-
motor impairment in the harmaline model.
We found that low-dose THIP caused partial but definite reduction
in harmaline tremor in WT mice. The WT littermates for the a6 colony
differed from those of the d colony in displaying less marked tremor
suppression, yet significant suppression at the lower dose of 2 mg/kg.
These differences may have arisen from the less complete back-crossing
of the a6 colony. Nonetheless, each genotype provided an important
finding: tremor suppression by THIP that occurred in WT mice was
absent in littermate mice that lacked the d subunit or in those that lacked
the a6 subunit.
The complete absence of any tremor suppression by low-dose THIP
in d KO mice indicates that low-dose THIP was unable to activate
a4bc or a6bc GABAA receptors to suppress tremor, although these
receptors are upregulated in d KO mice.16,17 Moreover, the complete
absence of tremor suppression by low-dose THIP in a6 KO signifies
that in the absence of this subunit, low-dose THIP was not able to
suppress tremor by activating any d or c GABAA receptors that did not
contain the a6 subunit. Together, these results are best interpreted as
indicating that THIP’s proximate anti-tremor mechanism involves
the activation of a6bd receptors, mainly expressed in the brain on
cerebellar granule cells.
GABAA a6bd receptors are also found on adult turtle spinal moto-
neurons, where they affect the monosynaptic reflex.28 Activation by
THIP of these receptors, if present in mice, would not be expected to
Figure 2. Effect of THIP on Harmaline-induced Tremor in Gabra6+/+
and –/– Littermates. (A) Motion power percentages are displayed as in
Figure 1 in Gabra6+/+ mice that received 0, 2, or 3 mg/kg. These wild-type mice
displayed robust 10–16 Hz harmaline tremor that was reduced by THIP, 2 and
3 mg/kg, compared with the 0 mg/kg group. (B) In contrast, littermate mice
lacking the a6 subunit failed to display any tremor suppression by THIP. Mean
and standard error of the mean are shown; *p , 0.05, **p , 0.01, two-tailed
Student t test.
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affect tremor, as harmaline tremor, like ET, is centrally generated.
GABAA a6bd receptors are also located on locus coeruleus neurons in
mice.29 Activation of these receptors by THIP would be expected to
enhance, not suppress, tremor, as lesions of this nucleus exacerbate
harmaline tremor, while electrical stimulation suppresses tremor in
rodents.30 The most likely site of THIP’s anti-tremor action via
GABAA a6bd receptors is the cerebellar granule cell, where they are
most abundantly expressed. A cerebellar site of action is consistent
with imaging evidence of cerebellar cortical involvement in the
harmaline model,26,27 and the finding that mutant mice lacking Purkinje
neurons display reduced harmaline tremor.31 It is also consistent with
the wealth of observations that the cerebellum is implicated in the
pathophysiology of ET,2 whereas several interventions that reduce tremor
act on the cerebellum, including transcranial magnetic stimulation3 and
low-dose alcohol.4,32
Activated cerebellar granule cell a6bd GABAA receptors are well
positioned to reduce cerebellar cortical hyperactivity inferred in meta-
bolic imaging studies in ET subjects,4 not only by inducing tonic inhibi-
tion, but by indirectly increasing Golgi cell firing and synaptic GABA
release.33 Our findings suggest that a drug that activates the a6bd
GABAA receptor would be effective in treating tremor in patients with
ET. Given the expression of a6bd receptors in other sites, there is
a potential for off-target effects. Alternatively, a drug that activates
a6bc2 receptors may also be anticipated to exert anti-tremor effects, as
these receptors are also abundant on cerebellar granule cells. However,
they are also present in the rat cochlear nucleus.34 Further, GABAA
receptors containing a6 are present in the hippocampus and trigeminal
ganglia in rats;35,36 and thus may also have potential for off-target
effects.
The present results suggest that other activators of a6bd receptors,
such as neuroactive steroids and low-dose alcohol, should also suppress
harmaline tremor, especially the latter in view of clinical observations
that many ET patients report tremor reduction with low-dose alcohol.
We are currently studying these agents. However, because such
agents, as well as THIP itself, non-specifically activate a4bd and a6bd
receptors, they are likely not ideally suitable for treating tremor, as the
widespread cerebral distribution of a4bd receptors provides the basis
of unwanted, off-target adverse effects. Indeed, THIP was evaluated
for non-tremor indications and abandoned. In the present study,
we were compelled to use low doses, 2–3 mg/kg, to avoid adverse
effects. It is likely that such low doses underestimated the ability of
selective a6bd receptor activation to suppress tremor. At 4–6 mg/kg,
THIP alters the EEG but not in Gabrd–/– mice.15 As the EEG is based
mainly on cerebral hemisphere activity, where a4bd receptors
dominate, it is likely that THIP’s effect on the EEG is mainly a4bd
mediated. More strikingly, it has been shown that, at 10 mg/kg, THIP
causes sedation, increased tail flick latency, and incoordination on the
rotarod test: all effects that are abolished in a4 KO mice.22 Thus, when
THIP was in effect rendered a6bd selective by using a4 KO mice,
these mice passed the rotarod test after treatment with a10 mg/kg
dose, which is much higher than the 3 mg/kg dose that was the
maximal dose tolerated in our straight wire testing. These observations
suggest that a drug that is specific for a6bd, without affecting a4bd
GABAA receptors, would not only provide high specificity in treating
tremor but is likely to be well tolerated. Moreover, such a medica-
tion may not elicit tolerance or withdrawal effects, as these were not
encountered with chronic dosing in rats or in a clinical trial of THIP
for insomnia.37,38
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